The U.S. and Western European Bone Graft report is presented as a Microsoft Powerpoint presentation (>180 slides) and contains more than 100 figures and tables that are ideal for marketing purposes.
The report is designed to provide a detailed overview of current bone graft substitute product and technology developments. The goals of the report are to identify market drivers, restraints and technological and business issues that will impact the bone graft substitutes market. The aims are to provide an improved understanding of the market and technology, so that decision-makers are able to evaluate and consider opportunities within the market.
The report focuses on the U.S. and Western European markets for bone graft substitutes. The report is broken down into three major market segments:
- Synthetic bone graft substitutes
- Demineralised bone matrices (DBMs)
- Bone morphogenic proteins (BMPs)
The report identifies key bone graft substitute products, including their individual histories and applications. Revenue forecasts, market shares and pricing information are reported for the three major market segments.
The information presented in this report has been collated from interviews with manufacturers, distributors, universities, orthopaedic surgeons, company literature, conference proceedings, and related company information.
Table of Contents
- Declaration
- Research Scope
- Research Methodology
Chapter 1 Introduction
- Bone Grafting
- Biological Activity of Bone Grafts
- Current Bone Graft Technologies and Applications
- Autografts
- Advantages of Autografts
- Limitations of Autografts
- Machined Allografts
- Advantages and Limitations of Machined Allografts
- Synthetic Bone Graft Substitutes
- Advantages and Limitations of Synthetic Bone Grafts
- Demineralised Bone Matrices (DBMs)
- Advantages and Limitations of DBMs
- Bone Morphogenic Proteins (BMPs)
- Advantages and Limitations of BMPs
- Comparative Properties of Autografts and Allografts
- Comparative Properties of Synthetic Bone Graft Substitutes
Chapter 2 Orthopaedic Procedures and Bone Graft Utilisation
- Bone Graft Utilisation in Orthopaedic Applications (U.S., 2004)
- Total Number of Spinal Fusion Procedures in U.S., 2004
- Total Number of Spinal Fusion Procedures by Selected Geographic Regions in the U.S., 2004
- Total Number of Spinal Fusion Procedures by Anatomy, U.S., 2004
- Bone Graft Utilisation in Orthopaedic Applications (Western Europe, 2004)
- Total Number of Spinal Fusion Procedures in Western Europe, 2004
- Total Number of Spinal Fusion Procedures by Selected Geographic Regions in Western Europe, 2004
- Total Number of Spinal Fusion Procedures by Anatomy, Western Europe, 2004
Chapter 3 The Synthetic Bone Graft Substitutes Market
- Market Drivers and Restraints
- Industry Challenges
- Products
- Calcibon
- Calcibon Granules
- Collapat II
- Endobon
- Calcigen S
- Calcigen PSI
- Pro-Osteon
- Mimix and QuickSet Mimix
- Norian SRS
- ChronOS
- CELLPLEX
- OSTEOSET
- MIIG 115 Minimally-Invasive Injectable Graft
- MIIG X3 High Strength Injectable Bone Graft for Compression Fractures
- Healos
- Conduit TCP
- JAX CS
- JAX TCP
- Cortoss
- Vitoss
- OsSatura TCP and OsSatura BCP
- Stimulan
- Allogran-N
- Allogran-R
- ApaPore
- Pore-Si
- Skelite
- BioFuse
- ReproBone
- Polygraft BGS
- NeuGraft Strip
- ?-BSM
- MBCP
- Cerasorb
- OpteMx
- Pricing Forecast for Synthetic Bone Graft Substitutes
- U.S. and Western European Market Size for Synthetic Bone Graft Substitutes
- U.S. Market Size for Synthetic Bone Graft Substitutes
- Western European Market Size for Synthetic Bone Graft Substitutes
- Western European Synthetic Bone Graft Substitutes Market by Geographic Region, 200
- Market Share, 2004
Chapter 4 Demineralised Bone Matrix (DBM) Market
- Market Drivers and Restraints
- Industry Challenges
- Products
- Dynagraft II Putty and Gel
- Orthoblast II Putty and Gel
- Accell Total Bone Matrix
- Accell Connexus
- Allomatrix Custom Bone Graft Putty
- Allomatrix DR Graft
- Allomatrix Injectable Putty
- IGNITE ICS Graft
- Osteoset 2 DBM Bone Graft Substitute with Bioassayed DBM
- Grafton DBM Matrix PLF
- Grafton DBM Crunch
- Grafton DBM Matrix Plugs
- Grafton DBM Flex
- Grafton DBM Putty
- Grafton DBM Gel
- Grafton Plus DBM Paste
- DBX Demineralised Bone Matrix Putty
- InterGro DBM Putty
- VIAGRAF DBM
- Cellect
- I/C Graft Chamber
- Optium DBM Gel
- Optium DBM Putty
- Osteofil RT DBM Paste
- Osteofil DBM Paste
- Osteofil RT ICM Mouldable Allografts
- Osteofil ICM Mouldable Strip
- Osteofil IC Mouldable Allograft Syringe
- Opteform
- Optefil
- Regenafil Allograft Paste
- Regenaform Allograft Paste
- Pricing Forecast for DBM
- Average Price Range of Various DBM Formulations
- Pricing Analysis
- U.S. and Western European Market Size for DBM
- U.S. Market Size for DBM
- Western European Market Size for DBM
- Revenue Analysis
- Western European DBM Market by Geographic Region
- Distribution Structure
- Market Share
- Market Share Analysis I
- Market Share Analysis II
Chapter 5 Bone Morphogenic Proteins (BMP) Market
- Market Drivers and Restraints
- Market Opportunities
- End-User Trends
- Industry Challenges
- BMP Products
- rhBMP-2/ACS (marketed as InFUSE Graft in the U.S., and as InductOS in Europe)
- History of rhBMP-2/ACS
- Product Description
- Development of rhBMP/ACS
- Preclinical Studies
- Clinical Studies
- Indications and Contradictions
- Development of InductOS in Europe
- OP-1
- Development of OP-1
- Product Description
- Preclinical Studies
- Clinical Studies
- FDA Indications and Contradictions
- MP52
- Product Description
- History of Development
- Preclinical and Clinical Studies
- FDA Status
- Pricing Analysis
- Pricing Forecasts for BMPs
- U.S. and Western European Market Size for BMPs
- U.S. Market Size for BMPs
- U.S. Unit Shipments of BMPs
- Analysis of Unit Shipment of BMPs in the U.S
- Western European Market Size for BMPs
- Western European Unit Shipments of BMPs
- Western European BMP Market by Geographic Region, 2004
- Surgeons Prospective
バイオテクノロジー
その他のカテゴリ
FAQ